Mail

Canada markets closed

S&P/TSX
22,308.93
-66.90(-0.30%)
S&P 500
5,222.68
+8.60(+0.16%)
DOW
39,512.84
+125.08(+0.32%)
CAD/USD
0.7317
+0.0006(+0.08%)
CRUDE OIL
78.20
-1.06(-1.34%)
Bitcoin CAD
83,156.20
-3,093.84(-3.59%)

MARKETS LIVE BLOG

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

Protagonist Therapeutics, Inc. (PGF.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR

Add to watchlist

15.20

0.00

(0.00%)

At close: 08:29PM CEST

Currency in EUR

Valuation Measures⁴

Market Cap (intraday)	726.44M
Enterprise Value	425.53M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	26.91
Price/Book (mrq)	2.35
Enterprise Value/Revenue	12.09
Enterprise Value/EBITDA	-3.32

Trading Information

Stock Price History

Beta (5Y Monthly)	2.08
52-Week Change ³	-11.63%
S&P500 52-Week Change ³	26.43%
52 Week High ³	42.80
52 Week Low ³	10.80
50-Day Moving Average ³	31.01
200-Day Moving Average ³	30.82

Share Statistics

Avg Vol (3 month) ³	179
Avg Vol (10 day) ³	180
Shares Outstanding ⁵	47.55M
Implied Shares Outstanding ⁶	N/A
Float ⁸	41.03M
% Held by Insiders ¹	1.24%
% Held by Institutions ¹	102.39%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	N/A
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	51.47%
Operating Margin (ttm)	80.92%

Management Effectiveness

Return on Assets (ttm)	21.38%
Return on Equity (ttm)	41.75%

Income Statement

Revenue (ttm)	314.95M
Revenue Per Share (ttm)	5.31
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	149.64M
Net Income Avi to Common (ttm)	162.11M
Diluted EPS (ttm)	-2.45
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	322.64M
Total Cash Per Share (mrq)	5.5
Total Debt (mrq)	462k
Total Debt/Equity (mrq)	0.08%
Current Ratio (mrq)	15.72
Book Value Per Share (mrq)	9.56

Cash Flow Statement

Operating Cash Flow (ttm)	-63.32M
Levered Free Cash Flow (ttm)	-154.68M